{
    "Trade/Device Name(s)": [
        "CAPILLARYS Hb A1c Kit",
        "Hb A1c CAPILLARY Calibrators",
        "Hb A1c CAPILLARY Controls"
    ],
    "Submitter Information": "SEBIA",
    "510(k) Number": "K122101",
    "Predicate Device Reference 510(k) Number(s)": [
        "K071132",
        "K021484",
        "K112550"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LCP",
        "JIS",
        "JJX"
    ],
    "Summary Letter Date": "December 6, 2012",
    "Summary Letter Received Date": "November 20, 2012",
    "Submission Date": "November 19, 2012",
    "Regulation Number(s)": [
        "21 CFR 864.7470"
    ],
    "Regulation Name(s)": [
        "Glycosylated hemoglobin assay"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Hemoglobin A1c"
    ],
    "Specimen Type(s)": [
        "Whole blood"
    ],
    "Specimen Container(s)": [
        "EDTA tube"
    ],
    "Instrument(s)/Platform(s)": [
        "CAPILLARYS 2 FLEX-PIERCING instrument"
    ],
    "Method(s)/Technology(ies)": [
        "Capillary electrophoresis"
    ],
    "Methodologies": [
        "Protein separation in alkaline buffer",
        "Automated capillary electrophoresis"
    ],
    "Submission Type(s)": [
        "Kit",
        "Calibrator",
        "Control",
        "Automated system",
        "Instrument",
        "Reagent",
        "Accessory",
        "Software"
    ],
    "Document Summary": "FDA 510(k) summary for CAPILLARYS Hb A1c kit, calibrators, and controls using CAPILLARYS 2 FLEX-PIERCING automated capillary electrophoresis for quantification of HbA1c in whole blood.",
    "Indications for Use Summary": "Separation and quantification of HbA1c glycated fraction of hemoglobin in human whole blood to monitor long-term glycemic control in individuals with diabetes mellitus, intended for professional in vitro diagnostic use.",
    "fda_folder": "Hematology"
}